Screener
Novavax NVAX Canada — Revenue from Contract with Customer, Excluding Assessed Tax
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 |
|---|---|---|---|---|
| United States | $38,437 | $198,183 | $134,530 | $237,593 |
| Canada | — | — | — | 575,670 |
| Europe | 1,118 | 3,627 | 21,264 | 11,712 |
| Rest of the world | 17,143 | 37,430 | 40,418 | 80,920 |
| Total revenue | $56,698 | $239,240 | $196,212 | $905,895 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's canada — revenue from contract with customer, excluding assessed tax?
- Novavax (NVAX) reported canada — revenue from contract with customer, excluding assessed tax of $0 in Q2 2026.
- What does canada — revenue from contract with customer, excluding assessed tax mean?
- This metric represents the total revenue recognized from product sales or service agreements within the Canadian geographic market, net of any sales-related taxes. It serves as a key indicator of the company's market penetration and commercial success in the region, reflecting the demand for its vaccine portfolio. Tracking this revenue stream helps investors assess the geographic diversification of the company's income and the effectiveness of its regional commercial strategy.
Ask your AI about Novavax's canada — revenue from contract with customer, excluding assessed tax.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude